Prof. Dr. ÖMER KARADAĞ

Yayın Ağı

Makaleler 69

1. T2 signal ratio enhances the diagnostic performance of apparent diffusion coefficient in differentiating orbital lymphoma from inflammatory mimickers

BULUT E. G., Gümeler E., Karakaya J., KILIÇ L., KARADAĞ Ö., KARLI OĞUZ H. K.

Diagnostic and Interventional Radiology , cilt.32, sa.4, ss.457-462, 2026 (SCI-Expanded, Scopus, TRDizin)

2. Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritis

ALİBAZ F., Kara M., ESATOĞLU S. N., KENAR ARTIN G., Uzun G. S., Ünlü B., et al.

Clinical and Experimental Rheumatology , cilt.44, sa.4, ss.647-662, 2026 (SCI-Expanded, Scopus)

3. Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study

Gallina G. D., Lanzillotta M., Maggioni S., Cariddi A., Danè G., Bayındır Akbaş A. N., et al.

Rheumatology (Oxford, England) , cilt.65, sa.3, 2026 (SCI-Expanded, Scopus)

4. Reply to "Correspondence on: EULAR/PRES endorsed recommendations for the management of FMF: 2024 update"

ÖZEN S., GÜL A., Santos C. S., SAĞ E., Lachmann H. J., Deschner J. K., et al.

Annals of the rheumatic diseases , cilt.85, sa.3, 2026 (SCI-Expanded, Scopus)

5. Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registry

Ata E. B., KILIÇ L., Fırlatan Yazgan B., Kart Bayram S. G., Ekici M., Ünaldı E., et al.

Clinical Rheumatology , cilt.45, sa.2, ss.781-789, 2026 (SCI-Expanded, Scopus)

6. Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide study

DEMİRCİ YILDIRIM T., Erpek E., Ulusoy B. Ö., Uzun G. S., YAZICI A., Kardaş R. C., et al.

Internal and Emergency Medicine , 2026 (SCI-Expanded, Scopus)

7. Türkiye Romatoloji Derneği ANCA ilişkili (asosiye) vaskülitler hastalık yönetimi kılavuzu

Karadag O., Duran E., Dağlı P. A., Gerçik Ö., Kardaş R. C., sahin d., et al.

Ulusal Romatoloji Dergisi , cilt.17, sa.3, ss.131-144, 2025 (Scopus, TRDizin)

8. VALIDITY AND RELIABILITY OF THE TURKISH TRANSLATION OF THE ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOMES (AAV-PRO) QUESTIONNAIRE

BİLGİN E., ÖZTÜRK E., Erpek E., Kocaayan H., Kardas R. C., KÜÇÜK H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.83, ss.2365, 2025 (SCI-Expanded, Scopus)

9. A rare disease with many faces: a multicentre registry of IgG4-related disease in children

KAYA AKCA Ü., KÖSE H., Kurt T., Ulu K., Guliyeva V., Kilbas G., et al.

RHEUMATOLOGY , cilt.64, sa.4, ss.2185-2192, 2025 (SCI-Expanded, Scopus)

10. Prospective assessment of glucocorticoid toxicity in rheumatology practice: a focus on the glucocorticoid toxicity index

Bahap-Kara M., SARIYILDIZ E., ZENGİN H. Y., KARADAĞ Ö., EKİNCİOĞLU A.

RHEUMATOLOGY , cilt.64, sa.3, ss.1010-1018, 2025 (SCI-Expanded, Scopus)

11. Idiopathic polyarteritis nodosa-does it still exist? Viewpoint 2: idiopathic polyarteritis nodosa is rare, but still exists

KARADAĞ Ö.

RHEUMATOLOGY , cilt.64, 2025 (SCI-Expanded, Scopus)

12. Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter Study

Di Matteo A., Di Donato S., Smerilli G., Becciolini A., Camarda F., Cauli A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.22-33, 2025 (SCI-Expanded, Scopus)

13. Commentary on IgG4-related uveitis. A French cohort and literature review

EKİCİ M., KADAYIFÇILAR S., BEZCİ AYGÜN F., KARADAĞ Ö.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.69, 2024 (SCI-Expanded, Scopus)

14. Long-term follow-up of anti-TNF treatment in adult and pediatric DADA2 patients: Insights from real-world data

AYAN G., BAŞARAN H. Ö., FIRLATAN B., KILIÇ L., BİLGİNER Y., ALİKAŞİFOĞLU M., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.27, sa.11, 2024 (SCI-Expanded, Scopus)

15. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies

Uzun G. S., GÖKÖZ Ö., ÖĞÜT B., HEPER A., Guresci S., KARDAŞ R. C., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.44, ss.2547-2554, 2024 (SCI-Expanded, Scopus)

16. Factors Associated with the Development of Anti-drug Antibodies to TNFi and the Consequences for Axial Spondyloarthritis: A Two-year Follow-up Study

Ediboglu E. D., Cinar M., KOZACI L. D., SOLMAZ D., Sargin G., KARADAĞ Ö., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.11, sa.3, ss.364-370, 2024 (ESCI, TRDizin)

17. Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry

SARIYILDIZ E., ÜNALDI E., KILIÇ L., KARADAĞ Ö., KALYONCU U., ERTENLİ A. İ., et al.

Acta Medica , cilt.55, sa.3, ss.214-221, 2024 (TRDizin)

18. Orbital Pseudotumor in Granulomatosis with Polyangiitis. Interim Analysis of Clinical Outcomes from a European Collaborative Observational Study

Moroni L., Gallina G., Lanzillotta M., Maggioni S., Benanti G., Cariddi A., et al.

ARTHRITIS & RHEUMATOLOGY , ss.5054-5057, 2024 (SCI-Expanded, Scopus)

19. Assessment of venous disease with different venous disease specific scales in Behçet's disease patients with deep vein thrombosis

AKSOY A., Colak S., YAĞIZ B., COŞKUN B. N., Omma A., SARI A., et al.

PHLEBOLOGY , cilt.39, ss.550-556, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study

Bahap-Kara M., SARIYILDIZ E., YARDIMCI G. K., KARADAĞ Ö., EKİNCİOĞLU A.

RHEUMATOLOGY AND THERAPY , cilt.11, sa.4, ss.1043-1055, 2024 (SCI-Expanded, Scopus)

21. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study

KARADAĞ Ö., BÖLEK E. Ç., AYAN G., Mohammad A. J., Grayson P. C., Pagnoux C., et al.

Arthritis and Rheumatology , cilt.76, sa.7, ss.1120-1129, 2024 (SCI-Expanded, Scopus)

22. IMMUNOGLOBULIN G4-RELATED THORACIC DISEASE: CLINICAL AND RADIOLOGICAL FINDINGS OF A TURKISH COHORT

Alkan A., DURHAN G., YARDIMCI G. K., Sertcelik U. O., Farisogullari B., Ariyurek M., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.41, sa.2, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study

Di Matteo A., Smerilli G., Di Donato S., Liu A. R., Becciolini A., Camarda F., et al.

Annals of the Rheumatic Diseases , cilt.83, sa.7, ss.847-857, 2024 (SCI-Expanded, Scopus)

24. REAL-LIFE DATA COMPARING THE LONG-TERM OUTCOME AND TREATMENT IN ADULT AND PEDIATRIC DADA2 PATIENTS: SINGLE CENTER EXPERIENCE OVER 10 YEARS

Ayan G., BAŞARAN H. Ö., BÖLEK E. Ç., FIRLATAN YAZGAN B., Bulat B., BATU AKAL E. D., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.1113-1114, 2024 (SCI-Expanded, Scopus)

25. Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study

Geraldes R., Santos M., Ponte C., Craven A., Barra L., Robson J. C., et al.

Journal of Neurology , cilt.271, sa.6, ss.3309-3320, 2024 (SCI-Expanded, Scopus)

26. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.

Internal and Emergency Medicine , cilt.19, sa.4, ss.1025-1034, 2024 (SCI-Expanded, Scopus)

27. LONG-TERM FOLLOW-UP AND RESULTS OF CHILDHOOD-ONSET ENTHESITIS-RELATED ARTHRITIS AND POLYARTHRITIS: HUR-BIO EXPERIENCE

Ata E. B., Kilic L., Bilgin E., Uzun G. S., Ayan G., Ekici M., et al.

ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus)

28. CENTRAL NERVOUS SYSTEM INVOLVEMENT OF ANCA-ASSOCIATED VASCULITIS IN A SINGLE CENTER - HUVAC EXPERIENCE

Ozen N. P. A., Bilgin E., Duran E., TOPÇUOĞLU M. A., Arsava E. M., Gocmen R., et al.

ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus)

29. REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

Yildirim T. D., Erpek E., Ulusoy B. O., Unaldi E., Cagdas O. S., Kardas R. C., et al.

ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus)

30. DIFFERENCES IN THE CHARACTERISTICS OF D2T/ NOND2T-RA PATIENTS AND FACTORS ASSOCIATED WITH D2T-RA AT B/TSDMARD START

Eken A., Ayan G., Ozsoy Z., Uzun G. S., Ekici M., Unaldi E., et al.

ANNALS OF THE RHEUMATIC DISEASES , 2024 (SCI-Expanded, Scopus)

31. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.

Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.

Clinical and experimental rheumatology , cilt.42, sa.4, ss.816-821, 2024 (SCI-Expanded, Scopus)

32. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study

Culerrier J., Nguyen Y., KARADAĞ Ö., SÖZEN ŞAHNE B., Yildrim T. D., Ögüt T. S., et al.

Rheumatology (United Kingdom) , cilt.63, sa.4, ss.999-1006, 2024 (SCI-Expanded, Scopus)

33. A close look at the nutritional status and mediterranean diet adherence in patients with behcet's syndrome

ERSOY N., BÖLEK E. Ç., Farisoǧullari B., Çinar N., Garipoǧlu G., Çolak S., et al.

Mediterranean Journal of Nutrition and Metabolism , cilt.17, sa.1, ss.43-52, 2024 (ESCI, Scopus)

34. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: Real life experience from the TReasure Registry

KARADAĞ Ö., Farisogullari B., YAĞIZ B., Erden A., Ademoglu Z., Kimyon G., et al.

Clinical and Experimental Rheumatology , cilt.42, sa.1, ss.130-137, 2024 (SCI-Expanded, Scopus)

35. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.

Can Bostan Ö., Duran E., Tuncay G., Cihanbeylerden M., Karadag Ö., Damadoglu E., et al.

The Journal of asthma : official journal of the Association for the Care of Asthma , cilt.60, sa.5, ss.931-937, 2023 (SCI-Expanded, Scopus)

36. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?

Duran E., Kilic L., Durhan G., Inkaya A. Ç., Guven G. S., Karakaya G., et al.

Annals of the rheumatic diseases , cilt.82, sa.4, 2023 (SCI-Expanded, Scopus)

37. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis.

Ponte C., Grayson P. C., Robson J. C., Suppiah R., Gribbons K. B., Judge A., et al.

Annals of the rheumatic diseases , cilt.81, sa.12, ss.1647-1653, 2022 (SCI-Expanded, Scopus)

38. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.

Grayson P. C., Ponte C., Suppiah R., Robson J. C., Gribbons K. B., Judge A., et al.

Annals of the rheumatic diseases , cilt.81, sa.12, ss.1654-1660, 2022 (SCI-Expanded, Scopus)

39. Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study

Di Matteo A., Cipolletta E., Castaniti G. M. D., Smerilli G., Airoldi C., Aydin S. Z., et al.

RHEUMATOLOGY , cilt.61, ss.4863-4874, 2022 (SCI-Expanded, Scopus)

40. Recurrent Aphthous Stomatitis and Related Factors in Turkish Adult Population: A Striking Outcome of Cappadocia Chronic Diseases Epidemiological Study

ÇALIK BAŞARAN N., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., ERDEN A., KILIÇ L., et al.

Cumhuriyet Tıp Dergisi (ELEKTRONİK) , cilt.44, sa.3, ss.233-238, 2022 (Hakemli Dergi)

41. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?

Farisogullari B., Cuceoglu M., Oral H., Yardimci G. K., Bilginer Y., Ozen S., et al.

Internal and emergency medicine , cilt.17, sa.6, ss.1599-1608, 2022 (SCI-Expanded, Scopus)

42. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis.

Grayson P. C., Ponte C., Suppiah R., Robson J. C., Craven A., Judge A., et al.

Annals of the rheumatic diseases , cilt.81, sa.3, ss.309-314, 2022 (SCI-Expanded, Scopus)

43. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.

Robson J. C., Grayson P. C., Ponte C., Suppiah R., Craven A., Judge A., et al.

Annals of the rheumatic diseases , cilt.81, sa.3, ss.315-320, 2022 (SCI-Expanded, Scopus)

44. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis.

Suppiah R., Robson J. C., Grayson P. C., Ponte C., Craven A., Khalid S., et al.

Annals of the rheumatic diseases , cilt.81, sa.3, ss.321-326, 2022 (SCI-Expanded, Scopus)

45. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

Ytterberg S. R., Bhatt D. L., Mikuls T. R., Koch G. G., Fleischmann R., Rivas J. L., et al.

The New England journal of medicine , cilt.386, sa.4, ss.316-326, 2022 (SCI-Expanded, Scopus)

46. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.

Farisoğulları B., Yardımcı G. K., Sarı A., Bilgin E., Bölek E. Ç., Duran E., et al.

Clinical and experimental rheumatology , cilt.40, sa.1, ss.112-119, 2022 (SCI-Expanded, Scopus)

47. Successful treatment of penile Mondor's disease with infliximab in a patient with Behçet's disease.

Özbek D. A., Bilgin E., Onur M. R., Karadağ Ö., Kiraz S.

Rheumatology (Oxford, England) , cilt.60, sa.11, 2021 (SCI-Expanded, Scopus)

48. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis.

Lanzillotta M., Della-Torre E., Wallace Z. S., Stone J. H., Karadag Ö., Fernández-Codina A., et al.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] , cilt.21, sa.7, ss.1395-1401, 2021 (SCI-Expanded, Scopus)

49. Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: is drug interaction the culprit?

DURAN E., BİLGİN E., BÖLEK E. Ç., FIRAT O., BULUT E. G., KALYONCU U., et al.

DRUG METABOLISM AND PERSONALIZED THERAPY , cilt.36, sa.2, ss.169-172, 2021 (Scopus)

50. Is Takayasu's arteritis more severe in children?

Bolek E., Kaya A., Sari A., Sag E., Demir S., Kilic L., et al.

Clinical and experimental rheumatology , sa.2, ss.32-38, 2021 (SCI-Expanded, Scopus)

51. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.

Monti S., Craven A., Klersy C., Montecucco C., Caporali R., Watts R., et al.

Rheumatology (Oxford, England) , cilt.60, sa.2, ss.617-628, 2021 (SCI-Expanded, Scopus)

52. Mediastinal mass in a patient with rheumatoid arthritis: lymphoid cystic thymic hyperplasia

ORAL H., BİLGİN E., YILDIRIM S., ÖNDER S. Ç., DEMİRKAZIK F., Serkan U., et al.

RHEUMATOLOGY ADVANCES IN PRACTICE , cilt.5, sa.2, 2021 (ESCI, Scopus)

53. Predictive factors for work-day loss in Behcet's syndrome: A multi-center study

MUMCU G., Yay M., Aksoy A., Tas M. N., ARMAĞAN B., SARI A., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2

Ozen S., Bilginer Y., Batu E., Taşkıran E., Özkara H. A., Ünal Ş., et al.

JOURNAL OF RHEUMATOLOGY , cilt.47, sa.1, ss.117-125, 2020 (SCI-Expanded, Scopus)

55. Two cases of glutaric aciduria type II: how to differentiate from inflammatory myopathies?

Koca M., Erden A., Armagan B., Sari A., Yildiz F., Ozdamar S., et al.

Acta clinica Belgica , cilt.74, sa.6, ss.451-455, 2019 (SCI-Expanded, Scopus)

56. Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritisanti-TNF

Duran E., Yildirim B. E. S., KARADAĞ Ö.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.5, sa.9, 2019 (SCI-Expanded, Scopus)

57. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behcet's syndrome: a multicentre study

Mumcu G., Karacayli U., Yay M., Aksoy A., Tas M. N., Armagan B., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.98-104, 2019 (SCI-Expanded, Scopus)

58. Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis.

Ortiz-Fernández L., Carmona F. D., López-Mejías R., González-Escribano M. F., Lyons P. A., Morgan A. W., et al.

Annals of the rheumatic diseases , cilt.77, sa.4, ss.589-595, 2018 (SCI-Expanded, Scopus)

59. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.

Aydin S. Z., Direskeneli H., Merkel P. A., Ytterberg S., Blockmans D., Sato E. I., et al.

The Journal of rheumatology , cilt.44, sa.12, ss.1928-1932, 2017 (SCI-Expanded, Scopus)

60. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.

Carmona F. D., Coit P., Saruhan-Direskeneli G., Hernández-Rodríguez J., Cid M. C., Solans R., et al.

Scientific reports , cilt.7, ss.43953, 2017 (SCI-Expanded, Scopus)

61. Systemic involvements and preferred treatments in a large cohort of Behçet's disease.

Yilmaz S., Karadag Ö., Yazisiz V., Altun B., Gezer M., Karaman M., et al.

Rheumatology international , cilt.33, sa.12, ss.3025-30, 2013 (SCI-Expanded, Scopus)

62. The presence of MEFV gene mutations in patients with primary osteoarthritis who require surgery.

Yilmaz S., Erdem H., Tunay S., Torun D., Genc H., Tunca Y., et al.

The Korean journal of internal medicine , cilt.28, sa.5, ss.594-8, 2013 (Scopus)

63. Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides.

Gok M., Erdem H., Gogus F., Yilmaz S., Karadag Ö., Simsek I., et al.

Rheumatology international , cilt.33, sa.4, ss.879-85, 2013 (SCI-Expanded, Scopus)

64. The factors considered as trigger for the attacks in patients with familial Mediterranean fever

Karadag Ö., TUFAN A., Yazisiz V., Ureten K., Yilmaz S., Cinar M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.33, sa.4, ss.893-897, 2013 (SCI-Expanded, Scopus)

65. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis

KISACIK B., Tufan A., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., OZTURK M. A., et al.

JOINT BONE SPINE , cilt.75, sa.3, ss.291-294, 2008 (SCI-Expanded, Scopus)

66. Risk of cancer in Turkish patients after treatment with TNF antagonists.

Pay S., Oztürk M. A., Can G., Cefle A., Cobankara V., Erer B., et al.

Rheumatology (Oxford, England) , cilt.47, sa.4, ss.548-9, 2008 (SCI-Expanded, Scopus)

67. Accurate diagnosis of acute abdomen in FMF and acute appendicitis patients: how can we use procalcitonin?

Kisacik B., Kalyoncu U., Erol M. F., Karadag Ö., Yildiz M., Akdogan A., et al.

CLINICAL RHEUMATOLOGY , cilt.26, sa.12, ss.2059-2062, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever

Tufan A., Babaoglu M. O., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al.

JOURNAL OF RHEUMATOLOGY , cilt.34, sa.7, ss.1540-1544, 2007 (SCI-Expanded, Scopus)

69. Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis.

Onal I. K., Dağdelen S., Atmaca A., Karadağ Ö., Adalar N.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists , cilt.12, sa.3, ss.299-301, 2006 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 142

1. IgG4-Related Pachymeningitis: How Do I Recognize?

ARSLAN D., Yardimci G., BABAOĞLU B., BÖLEK E. Ç., KILIÇ L., Saglam A., et al.

9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.656, (Özet Bildiri)

2. IMPACT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH AS USING BIOLOGIC AGENTS

Uzun G. S., YALÇIN ÇAKIR F., BİLGİN E., Farisogullari B., AYAN G., Ozsoy Z., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1695, (Özet Bildiri)

3. IDENTIFICATION OF HISTOPATHOLOGIC FINDINGS OF PATIENTS WITH GIANT CELL ARTERITIS: A MULTICENTRE STUDY IN THE ERA OF 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GCA

Uzun G. S., Gokoz O., Heper A., Ogut B. C., Guresci S., Omma A., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1584-1585, (Özet Bildiri)

4. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

Bolek E. C., AYAN G., BİLGİN E., Ediboglu E. D., Duran E., Kardas C., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1597-1598, (Özet Bildiri)

5. FACTORS ASSOCIATED WITH PERSISTENTLY HIGH HAQ-DI SCORE IN RA PATIENTS UNDER B/ TSDMARDS: LONGITUDINAL ANALYSIS OF HURBIO SINGLE CENTER REGISTRY

BİLGİN E., GÜVEN E., FIRLATAN B., Ekici M., Bayram G. S. K., Unaldi E., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.500, (Özet Bildiri)

6. EVALUATION OF THE EFFECT OF TUMOR NECROSIS FACTOR - A THERAPY ON 24-HOUR AMBULATORY BLOOD PRESSURE MEASUREMENT AND SLEEP QUALITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

Moral K., BİLGİN E., KARADAĞ Ö., Kalyoncu U., Akdogan A., Bilgen S. A., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1689, (Özet Bildiri)

7. Antiretroviral therapy causes a reduction in T-cell exhaustion, which is preserved after switching to a new therapy regimen

Özcan B., Tavukçuoğlu E., KARA E., Horzum U., AYAN G., SÖNMEZER M. Ç., et al.

18th European AIDS Conference (EACS 2021), London, Kanada, 27 Ekim 2021, cilt.1, ss.52-53, (Tam Metin Bildiri)

8. ROMATOİD ARTRİTLİ BİR HASTADA MEDİASTİNAL KİTLE: LENFOİD KİSTİK TİMİK HİPERPLAZİ

ORAL H., BİLGİN E., YILDIRIM S., ÖNDER S. Ç., DEMİRKAZIK F., UYSAL S., et al.

14. Anadolu Romatoloji Günleri, Online Kongre, 26 - 30 Mayıs 2021, (Özet Bildiri)

9. CONCOMITANT PSORIATIC ARTHRITIS AND INFLAMMATORY BOWEL DISEASE IN THE PSA BIOLOGICAL REGISTRY: HUR-BIO REAL LIFE RESULTS

Yardimci G. K., Farisogullari B., Armagan B., Bilgin E., Bolek E. C., Duran E., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1174-1175, (Özet Bildiri)

10. SUBPHENOTYPES IN POLYARTERITIS NODOSA (PAN): TARGET ORGAN ASSOCIATIONS OF A WORLDWIDE COLLABORATION STUDY

Karadag O., Bolek E. C., Furuta S., Emmi G., Hocevar A., Hinojosa-Azaola A., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1060-1061, (Özet Bildiri)

11. BIOSIMILAR INFLIXIMAB EXPERIENCE IN SPONDYLOARTRITIS PATIENTS: TREASURE REAL LIFE RESULTS

Bilge N. S. Y., Kasifoglu T., Kiraz S., Ertenli A. I., Dalkilic E., Bes C., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1616, (Özet Bildiri)

12. SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS

Armagan B., Kilic L., Yardimci G. K., Bilgin E., Farisogullari B., Bolek E. C., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.419-420, (Özet Bildiri)

13. LOCALISATION OF RHEUMATOID LUNG NODULES IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE: RIGHT OR LEFT?

Bilgin E., Ekici M., Baytar Y., Duran E., Durhan G., Bolek E. C., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.277, (Özet Bildiri)

14. EMERGING AUTOANTIBODIES PANEL (MYOSITIS ASSOCIATED AND MYOSITIS SPECIFIC ANTIBODIES) IN INFLAMMATORY MYOPATHIES: THE FREQUENCIES OF AND RELATIONSHIP WITH CLINICAL FEATURES

Yardimci G. K., Erul E., Bilgin E., Farisogullari B., Kilic L., Saribas Z., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1605-1606, (Özet Bildiri)

15. CONCOMITANT USE OF BIOLOGIC DMARDS WITH CSDMARDS INCREASES DRUG RETENTION RATE AND IMPROVES TREATMENT RESPONSE IN THE PSORIATIC ARTHRITIS. HUR-BIO REAL LIFE RESULTS

Duran E., Bilgin E., Bolek E. C., Yardimci G. K., Farisogullari B., Kilic L., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.757, (Özet Bildiri)

16. CONVENTIONAL SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS - CHANGING PRACTICE IN BIOLOGIC ERA: REAL-LIFE RESULTS FROM HURBIO-PSA REGISTRY

Bilgin E., Duran E., Bolek E. C., Farisogullari B., Yardimci G. K., Kilic L., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1663, (Özet Bildiri)

17. EFFICACY, RETENTION RATE AND PREDICTORS OF TOFACITINIB EFFICACY AND RETENTION IN RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL-LIFE EXPERIENCE

Bilgin E., Ceylan F., Bolek E. C., Duran E., Farisogullari B., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1460, (Özet Bildiri)

18. PREDICTORS AND SEVERITY OF POST-THROMBOTIC SYNDROME IN VASCULAR BEHCET'S DISEASE: RETROSPECTIVE MULTICENTER STUDY

Aksoy A., Colak S., Yagiz B., Seniz B. N., Omma A., Yildiz Y., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.367-368, (Özet Bildiri)

19. FACTORS RELATED TO RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

Kalyoncu U., Ekici M., Bilgin E., Sari A., Baytar Y., Bolek E. C., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1394, (Özet Bildiri)

20. THE INFLUENCE OF OBESITY ON BIOLOGICAL DMARD TREATMENT RESPONSE IN PSORIATIC ARTHRITIS: HUR-BIO REAL LIFE RESULTS

Farisogullari B., Yardimci G. K., Bolek E. C., Bilgin E., Duran E., Ayan G., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1675-1676, (Özet Bildiri) Sürdürülebilir Kalkınma

21. INFLAMMATORY ORBITAL DISEASES: THE EXPERIENCE OF A TERTIARY RHEUMATOLOGY CENTRE

Aksun M. S., Sahin T. K., Bolek E. C., Kilic L., Bulut E. G., Oguz K. K., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1806-1807, (Özet Bildiri)

22. CANCER INCIDENCE AND FEATURES IN ADULT VASCULITIS PATIENTS

Kardas R. C., Bolek E. C., Aktas B. Y., Kilickap S., Karadag O.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.682-683, (Özet Bildiri)

23. INCIDENCE RATE OF HERPES ZOSTER IN RHEUMATOID ARTHRITIS PATIENTS UNDER TOFACITINIB: REAL-LIFE DATA FROM TURKEY - HURBIO REGISTRY

Bilgin E., Ceylan F., Duran E., Bolek E. C., Farisogullari B., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.636, (Özet Bildiri)

24. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results

FARİSOĞULLARI B., YARDIMCI G. K., SARI A., ARMAĞAN B., BİLGİN E., BÖLEK E. Ç., et al.

2019 ACR/ARP Annual Meeting, 8 - 13 Kasım 2019, (Özet Bildiri)

25. Amyloidosis in Behcet’s Disease: Experience of a Vasculitis Centre at Silk Road

BÖLEK E. Ç., ERUL M. E., YARDIMCI G. K., KILIÇ L., AKDOĞAN A., KARADAĞ Ö.

2019 ACR/ARP Annual Meeting, ATLANTA, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)

26. Retention Rates and Response of Anti-TNF Treatments in the Enteropathic Spondylitis: HUR-BIO Real Life Results

YARDIMCI G. K., FARİSOĞULLARI B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.

2019 ACR/ARP Annual Meeting, ATLANTA, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)

27. Behçet Hastalığı’nda Hastaların Akdeniz Diyeti Uyumlarının Değerlendirilmesi veAntropometrik Ölçümlerine İncelenmesi: Kesitsel Pilot Çalışma

ERSOY N., BÖLEK E. Ç., Farisoğulları B., BİLGİN E., GARİPOĞLU G., KILIÇ L., et al.

20. Ulusal RomatolojiKongresi, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)

28. Alt ekstremite ağrılarının nadir bir sebebi:Erdheim-Chester hastalığı

DOĞAN Y., BÖLEK E. Ç., KARADAĞ Ö., AKINCI A.

20.ulusal romatoloji kongresi, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.135, (Tam Metin Bildiri)

29. Psöriatik artrit hastalar›nda 5 yıllık anti-TNF alfa kullanımı sonrasında subklinik aterosklerozun değişimi

ERDEN A., CANPOLAT U., UYAROĞLU O. A., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.

XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.233-234, (Özet Bildiri)

30. SAT0372 CHANGE OF SUBCLINICAL ATHEROSCLEROSIS AFTER FIVE YEARS ANTI-TNF TREATMENTS IN PSORIATIC ARTHRITIS

ERDEN A., CANPOLAT U., UYAROĞLU O., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 Haziran - 15 Aralık 2019, cilt.78, ss.1269, (Özet Bildiri)

31. AB0574 A MONOGENIC DISEASE WITH WIDE RANGE OF SYMPTOMS: DEFICIENCY OF ADENOSINE DEAMINASE 2

BATU AKAL E. D., TAŞKIRAN Z. E., TEZCAN F. İ., ÖZKARA H. A., ÇAĞDAŞ AYVAZ D. N., ÖZEN S., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1748, (Tam Metin Bildiri)

32. ENTEROPATHIC ARTHRITIS PATIENTS UNDER BDMARD TREATMENTS HAD FREQUENTLY RADIOGRAPHIC SACROILIITIS: HUR-BIO REAL LIFE RESULTS

YARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.478, (Özet Bildiri)

33. IS THERE AN OVERLAP OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES WITH IGG4-RELATED DISEASE OR NOT?

ERDEN A., BÖLEK E. Ç., YARDIMCI G. K., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.990, (Özet Bildiri)

34. OFF-LABEL USE OF BIOLOGICAL THERAPIES IN RELAPSING AND/OR REFRACTORY POLYARTERITIS NODOSA

Canzian A., KARADAĞ Ö., Contis A., Maurier F., Sartorelli S., Denis L., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1186-1187, (Özet Bildiri)

35. CLINICAL FEATURES OF ANEURYSMAL BEHCET DISEASE

ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1182, (Özet Bildiri)

36. UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITIS

Bilge N. S. Y., KAŞİFOĞLU T., KİRAZ S., ERTENLİ A. İ., Kucuksahin O., Dalkilic E., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.491, (Özet Bildiri)

37. ANEURYSM IN BEHCET'S DISEASE: MANAGEMENT, PROGNOSIS AND MORTALITY

ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.422, (Özet Bildiri)

38. VALIDATION OF A NOVEL DISEASE CLASSIFICATION IN HACETTEPE TAKAYASU ARTERITIS COHORT

BÖLEK E. Ç., DEMİR S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1192, (Özet Bildiri)

39. COMPARISON OF SURVIVAL RATES AMONG SUBGROUPS OF PATIENTS EVALUATED FOR FEVER OF UNKNOWN ORIGIN

BİLGİN E., ARMAĞAN B., SARI A., BÖLEK E. Ç., Farisogullari B., YARDIMCI G. K., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.573, (Özet Bildiri)

40. SMOKING MAY BE RELATED TO SACROILIITIS IN ENTEROPATHIC ARTHRITIS PATIENTS: TREASURE REAL-LIFE PRELIMINARY DATA

Kucuksahin O., ERDEN A., Ilgen U., KİRAZ S., ERTENLİ A. İ., Bilge N. S. Y., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1824-1825, (Özet Bildiri)